FDA Investigator Xiaoping Guan
Xiaoping Guan has inspections in 9 countries as of 23 Oct 2023. Xiaoping Guan has collaborated with a combinined 2532 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Italy,
France,
Germany,
Belgium,
United States of America,
United Kingdom of Great Britain and Northern Ireland,
China,
Austria,
Switzerland
Co-Investigator(s):
Addam S Reynolds,
Ademola O Daramola,
Aditi S Thakur,
Alice S Tsao,
Alicia M Mozzachio,
Amir Alavi,
Amy M Cramer,
Anastasia M Shields,
Andrea A Branche,
Anjali Shukla, PhD,
Ann M Stewart,
Aziz A Mamur,
Azza Talaat,
Barbara Jwilimczyk Macri,
Byungja E Marciante,
Camerson E Moore,
Carla J Lundi,
Caryn M Mcnab,
Charisse K Green,
Christine W Twohy,
Christopher S Keating,
Christopher T Middendorf,
Cynthia Jim, CSO,
Darren S Brown,
David Acevedo,
David K Lau,
David R Delucia,
Deborah Schmiel, PhD,
Demitria J Xiradakis,
Denise M Digiulio,
Dhaval H Patel,
Dr. Gang Wang, PhD,
Eric J Cunningham,
Erik W Koester,
Erika V Butler,
Evan Tong,
Felix Maldonado,
Francis A Guidry,
Frank J Marciniak,
German Rivera,
Gilbert T Salud,
Heika R Tait,
Iram R Hassan, PhD,
Ivis Lnegron Torres,
Jacqueline Mdiaz Albertini,
James A Liubicich,
James K Rice,
James L Dunnie, Jr,
Jean M Kelahan,
Jennifer J Stone,
Jennifer M Gogley,
Joey V Quitania,
Jose Alopez Rubet,
Jose M Cayuela,
Joy P Matthias,
Justin A Boyd,
Kathy E Craven,
Kathy E Noe,
Kelly I Anderson,
Kevin A Gonzalez,
Kevin D Kallander,
Kevin P Foley,
Kinh Q Mac,
Laura Fontan, MS,
Lawrence W Farina,
Lewis K Antwi,
Linda F Murphy,
Linda Thai,
Luella J Rossi,
Marcus F Yambot,
Margaret M Annes,
Maria Joselopez Barragan, PhD,
Marie F Morin,
Marijo B Kambere, PhD,
Marion Michaelis,
Marjorie A Shapiro, PhD,
Maryam Tabatabaie,
Matthew A Spataro,
Maya M Davis,
Meyer J Slobotsky,
Michael E Maselli,
Michael J Kuchta,
Michael Levin,
Michael Shanks, MS,
Mihaly S Ligmond,
Mra B Kamberem,
Mra M Barbosar,
Mra Mcculloughj,
Nicholas A Vicland,
Nicholas A Violand,
Noreen Muniz,
Omotunde O Osunsanmi,
Patricia Fhughes Troost,
Patrick C Klotzbuecher,
Paul A Bonneau,
Paul L Bellamy,
Paul L Figarole, Jr,
Paul Mouris,
Paula A Trost,
Perry T Nichols,
Peter Adams, PhD,
Prabhu P Raju,
Rachel C Harrington,
Ramon E Martinez,
Raymond T Oji,
Regina T Brown,
Reyes Candau Chacon, PhD,
Richard J Friedman,
Richard L Friedman,
Robert C Coleman,
Robert C Steyert,
Robert M Barbosa,
Rochelle K Kimmel,
Roy R Rinc,
Russell J Glapion,
Samina S Khan,
Sangeeta M Khurana, PhD,
Sarah Forney,
Satheesh Thomas,
Scott R Nichols, PhD,
Scott T Ballard,
Shari L Kahn,
Shirley J Berryman,
Simone E Pitts,
Stephanie A Slater, MS,
Stephen D Brown,
Steven M Weinman,
Steven P Donald,
Susan M Jackson,
Susan P Bruederle,
Syeda N Mahazabin,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Uduak M Inokon,
Vanessa M Williams,
Vincent M Williams,
Wayne E Seifert,
William Hallett, PhD,
Xiaokuang Lai, PhD,
Yumi J Hiramine,
Zhong Li, PhD
Xiaoping Guan's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| May, 2015 | FDA 483 | Patheon Italia S.p.A - Form 483, 2015-05-19 |
| May, 2015 | FDA 483 | Corden Pharma Latina S.p.A. - Form 483, 2015-05-29 |
| September, 2015 | FDA 483 | Excelsior Medical LLC - Form 483, 2015-09-29 |
| September, 2017 | EIR | Bioreliance Ltd. - EIR, 2017-09-22 |
| July, 2016 | FDA 483 | Sandoz GmbH - Form 483, 2016-07-05 |
| August, 2014 | FDA 483 | Excelsior Medical LLC - Form 483, 2014-08-21 |
| December, 2013 | EIR | Epic Pharma, LLC - EIR, 2013-12-23 |
| July, 2016 | FDA 483 | CORDEN PHARMA SPA - Form 483, 2016-07-15 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more